EAST HANOVER, N.J., June 5 /PRNewswire/ -- The US Food and Drug Administration (FDA) has broadened the US indication for once-yearly Reclast(R) (zoledronic acid) Injection to include the prevention of ...

Treatments for postmenopausal osteoporosis were generally misaligned with current guidelines among women at very high risk for fracture.

Study of more than 2,100 patients who suffered a hip fracture shows 35% reduction in subsequent osteoporotic fractures in Aclasta-treated patients Results published in The New England Journal of ...

Please provide your email address to receive an email when new articles are posted on . “There is abundant evidence that men are not adequately screened for osteoporosis, and those with osteoporosis ...

Credit: Shutterstock. The hospital preference instrumental variable had a stronger association with treatment than the other 3 instrumental variables (specialist access, calendar year, and geographic ...

According to a recent meta-analysis, no significant association was observed between pharmacotherapies used for osteoporosis treatment and mortality rate, despite previous studies suggesting the ...

The X-ray of a spine super-imposed on a woman’s back illustrates the importance of monitoring and treatment of osteoporosis. Women are most at risk for osteoporosis because of the sudden loss of ...

Osteoporosis is a common disorder among postmenopausal women which results in an increased risk of fractures. While several therapies improve bone strength and reduce the risk of spine and hip ...